JP2009544315A - 糖化ヘモグロビンのパーセントを定量するための方法 - Google Patents
糖化ヘモグロビンのパーセントを定量するための方法 Download PDFInfo
- Publication number
- JP2009544315A JP2009544315A JP2009521827A JP2009521827A JP2009544315A JP 2009544315 A JP2009544315 A JP 2009544315A JP 2009521827 A JP2009521827 A JP 2009521827A JP 2009521827 A JP2009521827 A JP 2009521827A JP 2009544315 A JP2009544315 A JP 2009544315A
- Authority
- JP
- Japan
- Prior art keywords
- glycated
- hemoglobin
- protease
- amino acid
- oxidant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000017011 Glycated Hemoglobin A Human genes 0.000 title claims abstract description 93
- 238000000034 method Methods 0.000 title claims abstract description 88
- 108091005995 glycated hemoglobin Proteins 0.000 title claims abstract description 48
- 239000007800 oxidant agent Substances 0.000 claims abstract description 133
- 108091005804 Peptidases Proteins 0.000 claims abstract description 89
- 239000004365 Protease Substances 0.000 claims abstract description 89
- 210000004369 blood Anatomy 0.000 claims abstract description 87
- 239000008280 blood Substances 0.000 claims abstract description 87
- 102000001554 Hemoglobins Human genes 0.000 claims abstract description 58
- 108010054147 Hemoglobins Proteins 0.000 claims abstract description 58
- 108010078123 amadoriase Proteins 0.000 claims abstract description 50
- 102000003992 Peroxidases Human genes 0.000 claims abstract description 36
- 108040007629 peroxidase activity proteins Proteins 0.000 claims abstract description 34
- 239000000126 substance Substances 0.000 claims abstract description 28
- 238000005259 measurement Methods 0.000 claims abstract description 14
- 235000019419 proteases Nutrition 0.000 claims description 80
- 230000001590 oxidative effect Effects 0.000 claims description 63
- 239000012139 lysis buffer Substances 0.000 claims description 58
- 108010014663 Glycated Hemoglobin A Proteins 0.000 claims description 45
- 150000001413 amino acids Chemical class 0.000 claims description 40
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 40
- 239000000203 mixture Substances 0.000 claims description 37
- 239000012634 fragment Substances 0.000 claims description 30
- 108090000623 proteins and genes Proteins 0.000 claims description 29
- 102000004169 proteins and genes Human genes 0.000 claims description 28
- 238000011088 calibration curve Methods 0.000 claims description 26
- NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical group C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 claims description 26
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 20
- 210000003743 erythrocyte Anatomy 0.000 claims description 18
- -1 N-carboxymethylaminocarbonyl Chemical group 0.000 claims description 17
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 15
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 12
- GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 claims description 12
- HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 claims description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 11
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 10
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 9
- 210000000601 blood cell Anatomy 0.000 claims description 9
- 239000003638 chemical reducing agent Substances 0.000 claims description 9
- 239000004474 valine Substances 0.000 claims description 9
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 8
- 239000004471 Glycine Substances 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 6
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims description 6
- SMBKJPHMYWYRDF-UHFFFAOYSA-M sodium 4-[2-(2,4-dinitrophenyl)-3-(4-iodophenyl)-1,3-dihydrotetrazol-3-ium-5-yl]benzene-1,3-disulfonate Chemical group [Na+].[O-][N+](=O)C1=CC([N+](=O)[O-])=CC=C1N1[NH+](C=2C=CC(I)=CC=2)N=C(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)N1 SMBKJPHMYWYRDF-UHFFFAOYSA-M 0.000 claims description 6
- 108091005507 Neutral proteases Proteins 0.000 claims description 5
- 102000035092 Neutral proteases Human genes 0.000 claims description 5
- 208000035475 disorder Diseases 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 241000228212 Aspergillus Species 0.000 claims description 4
- 108090000145 Bacillolysin Proteins 0.000 claims description 4
- 108010067770 Endopeptidase K Proteins 0.000 claims description 4
- 108090000787 Subtilisin Proteins 0.000 claims description 4
- 108090001109 Thermolysin Proteins 0.000 claims description 4
- 125000000539 amino acid group Chemical group 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 3
- 241000283690 Bos taurus Species 0.000 claims description 3
- 108010059712 Pronase Proteins 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 206010012601 diabetes mellitus Diseases 0.000 claims description 3
- 238000003745 diagnosis Methods 0.000 claims description 3
- 238000004393 prognosis Methods 0.000 claims description 3
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 2
- 229950000688 phenothiazine Drugs 0.000 claims description 2
- CWLYDTVACYGEPD-UHFFFAOYSA-M sodium;2-[[3,7-bis(dimethylamino)phenothiazine-10-carbonyl]amino]acetate Chemical compound [Na+].C1=C(N(C)C)C=C2SC3=CC(N(C)C)=CC=C3N(C(=O)NCC([O-])=O)C2=C1 CWLYDTVACYGEPD-UHFFFAOYSA-M 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 21
- 238000004040 coloring Methods 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 102000035195 Peptidases Human genes 0.000 abstract description 68
- 238000006911 enzymatic reaction Methods 0.000 abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 35
- 238000002835 absorbance Methods 0.000 description 17
- 108091006146 Channels Proteins 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 14
- 229940088598 enzyme Drugs 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000007857 degradation product Substances 0.000 description 12
- 230000002255 enzymatic effect Effects 0.000 description 9
- 230000003647 oxidation Effects 0.000 description 9
- 238000007254 oxidation reaction Methods 0.000 description 9
- 238000008479 Hemoglobin A1c Assay Methods 0.000 description 8
- 238000003556 assay Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 102000004316 Oxidoreductases Human genes 0.000 description 7
- 108090000854 Oxidoreductases Proteins 0.000 description 7
- 125000003275 alpha amino acid group Chemical group 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- 238000006731 degradation reaction Methods 0.000 description 6
- 238000013467 fragmentation Methods 0.000 description 6
- 238000006062 fragmentation reaction Methods 0.000 description 6
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 6
- 108091005996 glycated proteins Proteins 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000007987 MES buffer Substances 0.000 description 5
- 229920004890 Triton X-100 Polymers 0.000 description 5
- 239000013504 Triton X-100 Substances 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 238000001952 enzyme assay Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000008000 CHES buffer Substances 0.000 description 3
- DCNMIDLYWOTSGK-HSUXUTPPSA-N D-glucosone Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)C=O DCNMIDLYWOTSGK-HSUXUTPPSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- MKWKNSIESPFAQN-UHFFFAOYSA-N N-cyclohexyl-2-aminoethanesulfonic acid Chemical compound OS(=O)(=O)CCNC1CCCCC1 MKWKNSIESPFAQN-UHFFFAOYSA-N 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 230000006325 deglycation Effects 0.000 description 3
- 230000036252 glycation Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000003691 Amadori rearrangement reaction Methods 0.000 description 2
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 2
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 2
- CXRFDZFCGOPDTD-UHFFFAOYSA-M Cetrimide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)C CXRFDZFCGOPDTD-UHFFFAOYSA-M 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- 108700020962 Peroxidase Proteins 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000009739 binding Methods 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000013618 particulate matter Substances 0.000 description 2
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- VHYHKZFQXUYNSG-UHFFFAOYSA-M sodium;4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-1,3-dihydrotetrazol-3-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].C1=CC([N+](=O)[O-])=CC=C1N1[NH+](C=2C=CC(I)=CC=2)N=C(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)N1 VHYHKZFQXUYNSG-UHFFFAOYSA-M 0.000 description 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- MIIIXQJBDGSIKL-UHFFFAOYSA-N 2-morpholin-4-ylethanesulfonic acid;hydrate Chemical compound O.OS(=O)(=O)CCN1CCOCC1 MIIIXQJBDGSIKL-UHFFFAOYSA-N 0.000 description 1
- 241001147780 Alicyclobacillus Species 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 108010024957 Ascorbate Oxidase Proteins 0.000 description 1
- 241000228257 Aspergillus sp. Species 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108090000712 Cathepsin B Proteins 0.000 description 1
- 102000004225 Cathepsin B Human genes 0.000 description 1
- 102100023336 Chymotrypsin-like elastase family member 3B Human genes 0.000 description 1
- 101000851141 Crotalus molossus nigrescens Snake venom metalloproteinase Proteins 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 101150096839 Fcmr gene Proteins 0.000 description 1
- 238000010268 HPLC based assay Methods 0.000 description 1
- 102000007513 Hemoglobin A Human genes 0.000 description 1
- 108010085682 Hemoglobin A Proteins 0.000 description 1
- 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
- 101000907951 Homo sapiens Chymotrypsin-like elastase family member 3B Proteins 0.000 description 1
- 108010053229 Lysyl endopeptidase Proteins 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- AFMJXHCACGGCKC-UHFFFAOYSA-N [Th].OC1=CC=C(C(=O)OC)C=C1 Chemical class [Th].OC1=CC=C(C(=O)OC)C=C1 AFMJXHCACGGCKC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- 108010027597 alpha-chymotrypsin Proteins 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 238000009459 flexible packaging Methods 0.000 description 1
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical group OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 125000001151 peptidyl group Chemical group 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 1
- 239000001230 potassium iodate Substances 0.000 description 1
- 235000006666 potassium iodate Nutrition 0.000 description 1
- 229940093930 potassium iodate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- AGDSCTQQXMDDCV-UHFFFAOYSA-M sodium;2-iodoacetate Chemical compound [Na+].[O-]C(=O)CI AGDSCTQQXMDDCV-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
- G01N33/723—Glycosylated haemoglobin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/104998—Glucose, ketone, nitrate standard or control
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83339006P | 2006-07-25 | 2006-07-25 | |
| US85880906P | 2006-11-13 | 2006-11-13 | |
| PCT/US2007/016774 WO2008013874A1 (en) | 2006-07-25 | 2007-07-25 | Methods for assaying percentage of glycated hemoglobin |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012186627A Division JP5878096B2 (ja) | 2006-07-25 | 2012-08-27 | 糖化ヘモグロビンのパーセントを定量するための方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2009544315A true JP2009544315A (ja) | 2009-12-17 |
Family
ID=38645830
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009521827A Withdrawn JP2009544315A (ja) | 2006-07-25 | 2007-07-25 | 糖化ヘモグロビンのパーセントを定量するための方法 |
| JP2012186627A Expired - Fee Related JP5878096B2 (ja) | 2006-07-25 | 2012-08-27 | 糖化ヘモグロビンのパーセントを定量するための方法 |
| JP2013207006A Pending JP2013255519A (ja) | 2006-07-25 | 2013-10-02 | 糖化ヘモグロビンのパーセントを定量するための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012186627A Expired - Fee Related JP5878096B2 (ja) | 2006-07-25 | 2012-08-27 | 糖化ヘモグロビンのパーセントを定量するための方法 |
| JP2013207006A Pending JP2013255519A (ja) | 2006-07-25 | 2013-10-02 | 糖化ヘモグロビンのパーセントを定量するための方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7855079B2 (https=) |
| EP (1) | EP2044444B1 (https=) |
| JP (3) | JP2009544315A (https=) |
| CN (1) | CN101484809B (https=) |
| AU (1) | AU2007277201B2 (https=) |
| CA (1) | CA2654981C (https=) |
| ES (1) | ES2404059T3 (https=) |
| WO (1) | WO2008013874A1 (https=) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012173185A1 (ja) * | 2011-06-17 | 2012-12-20 | 協和メデックス株式会社 | 糖化ヘモグロビンの測定方法、測定試薬、及び、測定キット |
| WO2013118743A1 (ja) * | 2012-02-09 | 2013-08-15 | 協和メデックス株式会社 | アスコルビン酸の影響抑制方法 |
| JPWO2012020744A1 (ja) * | 2010-08-11 | 2013-10-28 | 協和メデックス株式会社 | 糖化ヘモグロビンの測定方法 |
| WO2015005257A1 (ja) * | 2013-07-09 | 2015-01-15 | 協和メデックス株式会社 | 糖化ヘモグロビンの測定方法 |
| JPWO2014192200A1 (ja) * | 2013-05-31 | 2017-02-23 | パナソニックヘルスケアホールディングス株式会社 | 糖化ヘモグロビンを定量する方法 |
| WO2018101389A1 (ja) * | 2016-11-30 | 2018-06-07 | 東洋紡株式会社 | ヘモグロビンの糖化率測定方法 |
| WO2021192466A1 (ja) * | 2020-03-26 | 2021-09-30 | 日立化成ダイアグノスティックス・システムズ株式会社 | ヘモグロビンの影響軽減方法、糖化ヘモグロビンの測定方法、糖化ヘモグロビン測定試薬、及び糖化ヘモグロビン測定キット |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0610792D0 (en) * | 2006-06-02 | 2006-07-12 | Remynd Nv | Methods and tools for the screening of factors affecting protein misfolding |
| ES2404059T3 (es) * | 2006-07-25 | 2013-05-23 | General Atomics | Procedimientos para analizar el porcentaje de hemoglobina glicada |
| US7943385B2 (en) | 2006-07-25 | 2011-05-17 | General Atomics | Methods for assaying percentage of glycated hemoglobin |
| EP2283149A1 (en) * | 2008-05-13 | 2011-02-16 | General Atomics | Electrochemical biosensor for direct determination of percentage of glycated hemoglobin |
| JP5554000B2 (ja) * | 2009-02-19 | 2014-07-23 | 積水メディカル株式会社 | 糖化ヘモグロビン測定用試料の測定方法 |
| CN102413704A (zh) * | 2009-04-28 | 2012-04-11 | 帝斯曼知识产权资产管理有限公司 | 用于改进基于豆类的制品的方法 |
| EP2433140B1 (en) | 2009-05-20 | 2015-02-11 | Relia Diagnostic Systems, Inc. | Systems and methods for determining the percentage of glycated hemoglobin |
| JP2012108112A (ja) * | 2010-10-27 | 2012-06-07 | Arkray Inc | HbA1c測定結果の表示方法、表示装置、及び表示プログラム |
| TW201312118A (zh) * | 2011-09-15 | 2013-03-16 | Toyo Boseki | 糖化血紅素測量用多層試驗片、及使用它之測量方法 |
| CN102692411B (zh) * | 2012-06-08 | 2016-12-14 | 上海蓝怡科技股份有限公司 | 一种测定糖化血红蛋白百分比的试剂 |
| CN105044053B (zh) * | 2012-11-14 | 2017-11-03 | 广西安仁欣生物科技有限公司 | 基于核酸适体荧光探针的糖化血红蛋白试剂盒及其检测方法 |
| CN104164473A (zh) * | 2013-05-16 | 2014-11-26 | 北京豪迈生物工程有限公司 | 糖化白蛋白酶法检测试剂盒及其检测方法 |
| ES2848705T3 (es) * | 2013-08-09 | 2021-08-11 | Kikkoman Corp | Amadoriasa modificada y método para producirla, agente para mejorar la resistencia a tensioactivos de la amadoriasa y composición para medir la HbA1c usando la misma |
| CN106461682B (zh) | 2014-05-06 | 2018-09-21 | 德赛诊断系统有限公司 | HbA1c的酶促测定 |
| EP3239709B1 (en) * | 2016-04-25 | 2019-06-05 | ARKRAY, Inc. | Method of analyzing glycated protein; use of analysis reagent, analysis kit, and test piece for analysis |
| IT201700070452A1 (it) * | 2017-06-23 | 2018-12-23 | Fondazione St Italiano Tecnologia | Thermostabilized amadoriases and uses thereof |
| CN109682796A (zh) | 2017-10-02 | 2019-04-26 | 爱科来株式会社 | 糖化蛋白质的测定 |
| CN108732222B (zh) * | 2018-05-21 | 2020-02-18 | 浙江工业大学 | 一种同时快速检测血液中糖化血红蛋白和糖化血清蛋白的方法 |
| CN109596834B (zh) * | 2018-10-18 | 2021-09-10 | 东软威特曼生物科技(南京)有限公司 | 一种应用于体外诊断试剂的表面活性剂组合物 |
| JP7182724B2 (ja) * | 2019-02-15 | 2022-12-02 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド | 患者の液体試験サンプル中の糖化ヘモグロビンパーセントを決定するためのキャリブレーターおよびコントロール |
| CN110297048A (zh) * | 2019-07-12 | 2019-10-01 | 上海交通大学 | 一种抗干扰的糖化血红蛋白同系物相对含量的测定方法 |
| WO2021016380A1 (en) * | 2019-07-22 | 2021-01-28 | Ortho-Clinical Diagnostics, Inc. | Glycated hemoglobin measurement |
| CN110687306B (zh) * | 2019-10-30 | 2023-04-25 | 深圳上泰生物工程有限公司 | 一种直接机上溶血酶法双试剂糖化血红蛋白检测试剂盒 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000210100A (ja) * | 1998-11-17 | 2000-08-02 | Kdk Corp | 酸化還元反応を用いた測定方法 |
| WO2002006519A1 (en) * | 2000-07-14 | 2002-01-24 | Arkray, Inc. | Method of selectively determining glycated hemoglobin |
| WO2002021142A1 (en) * | 2000-09-07 | 2002-03-14 | Wako Pure Chemical Industries, Ltd. | Method of quantifying total hemoglobin and glycohemoglobin |
| WO2005017136A1 (en) * | 2003-07-17 | 2005-02-24 | General Atomics | Methods and compositions for determination of glycated proteins |
Family Cites Families (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2713581A (en) * | 1949-02-23 | 1955-07-19 | Montclair Res Corp | Certain tetrazolium salts and process for preparing them |
| GB738585A (en) | 1952-07-17 | 1955-10-19 | May & Baker Ltd | Improvements in or relating to tetrazolium compounds |
| GB1513488A (en) | 1976-11-11 | 1978-06-07 | Lushina O | Method of preparing 2h-tetrazolium chlorides and 2h-tetrazolium chlorides hydrochlorides |
| GB8308483D0 (en) | 1983-03-28 | 1983-05-05 | Health Lab Service Board | Secretion of gene products |
| US4588684A (en) * | 1983-04-26 | 1986-05-13 | Chiron Corporation | a-Factor and its processing signals |
| CA1226036A (en) | 1983-05-05 | 1987-08-25 | Irving J. Higgins | Analytical equipment and sensor electrodes therefor |
| US5509410A (en) | 1983-06-06 | 1996-04-23 | Medisense, Inc. | Strip electrode including screen printing of a single layer |
| US5682884A (en) * | 1983-05-05 | 1997-11-04 | Medisense, Inc. | Strip electrode with screen printing |
| JPS59219270A (ja) * | 1983-05-30 | 1984-12-10 | Wako Pure Chem Ind Ltd | テトラゾリウム塩を含有する溶液の安定化方法 |
| BE901119A (fr) | 1984-11-23 | 1985-03-15 | Wallone Region | Procede de preparation de plasmides vecteurs capables de transformer un hote bacterien escherichia coli et d'y promouvoir et controler l'expression d'un adn heterologue. |
| US4571488A (en) | 1985-01-29 | 1986-02-18 | E. I. Du Pont De Nemours And Company | Heat-fusion pipe fitting system |
| EP0196864A3 (en) | 1985-03-25 | 1988-03-23 | Cetus Corporation | Alkaline phosphatase-mediated processing and secretion of recombinant proteins, dna sequences for use therein and cells transformed using such sequences |
| US4948729A (en) * | 1985-03-25 | 1990-08-14 | Cetus Corporation | Production of soluble recombinant proteins |
| ATE72831T1 (de) * | 1985-05-31 | 1992-03-15 | Syntex Inc | Konjugate von glucose-6-phosphat-dehydrogenase, ihre herstellung und verwendung. |
| DE3611227A1 (de) * | 1986-04-04 | 1987-10-08 | Boehringer Mannheim Gmbh | Verfahren und reagenz zur bestimmung von substraten oder enzymaktivitaeten |
| US5196314A (en) * | 1986-04-04 | 1993-03-23 | Boehringer Mannheim Gmbh | Process and reagent for the determination of substrates or enzyme activities |
| US5030563A (en) * | 1987-07-07 | 1991-07-09 | Genetics Institute, Inc. | Bacterial hypersecretion using mutant repressor sequence |
| CA1335357C (en) * | 1987-10-30 | 1995-04-25 | Timothy M. Rose | Expression systems for preparation of polypeptides in prokaryotic cells |
| JP2970811B2 (ja) | 1987-10-30 | 1999-11-02 | オンコゲン ア リミテッド パートナーシップ | 原核生物細胞中にポリペプチドを調製するための発現システム |
| DE68924026T3 (de) * | 1988-03-31 | 2008-01-10 | Matsushita Electric Industrial Co., Ltd., Kadoma | Biosensor und dessen herstellung. |
| US5516682A (en) * | 1988-07-05 | 1996-05-14 | University Of Maryland | Subtilin variant of enhanced stability and activity |
| JP2742281B2 (ja) * | 1988-12-29 | 1998-04-22 | 旭化成工業株式会社 | グルコース―6―リン酸デヒドロゲナーゼ遺伝子 |
| EP0467978A4 (en) | 1989-04-13 | 1992-03-11 | Enzymatics, Inc. | The use of fluid insoluble oxidizing agents to eliminate interfering substances in oxidation-reduction measuring systems |
| USRE37919E1 (en) | 1989-05-12 | 2002-12-03 | The General Hospital Corporation | Recombinant DNA method for production of parathyroid hormone |
| US5171670A (en) * | 1989-05-12 | 1992-12-15 | The General Hospital Corporation | Recombinant dna method for production of parathyroid hormone |
| JP2796150B2 (ja) * | 1989-12-20 | 1998-09-10 | 株式会社ヤトロン | フルクトサミンの測定方法 |
| US5320732A (en) * | 1990-07-20 | 1994-06-14 | Matsushita Electric Industrial Co., Ltd. | Biosensor and measuring apparatus using the same |
| DE4024158A1 (de) * | 1990-07-30 | 1992-02-06 | Boehringer Mannheim Gmbh | Klonierung und ueberexpression von glucose-6-phosphat-dehydrogenase aus leuconostoc dextranicus |
| US5244796A (en) * | 1990-10-12 | 1993-09-14 | Syracuse University | Cloned leuconostoc mesenteroides glucose-6-phosphate dehydrogenase genes and method of making glucose-6-phospate dehydrogenase |
| MY107664A (en) * | 1991-01-17 | 1996-05-30 | Kao Corp | Novel alkaline proteinase and process for producing the same |
| US5593852A (en) * | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
| AU2592692A (en) | 1991-09-20 | 1993-04-27 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Isolation and characterization of cdna of plasmodium falciparum glucose-6-phosphate dehydrogenase |
| US5385846A (en) | 1993-06-03 | 1995-01-31 | Boehringer Mannheim Corporation | Biosensor and method for hematocrit determination |
| US5789221A (en) * | 1994-03-03 | 1998-08-04 | Kyogo Daiichi Kagaku Co., Ltd. | Fructosyl amino acid oxidase and process for producing the same |
| CA2156226C (en) * | 1994-08-25 | 1999-02-23 | Takayuki Taguchi | Biological fluid analyzing device and method |
| US5712138A (en) * | 1994-10-05 | 1998-01-27 | Kyoto Daiichi Kagaku Co., Ltd. | Fructosyl amino acid oxidase |
| IL117350A0 (en) | 1995-03-09 | 1996-07-23 | Procter & Gamble | Proteinase k variants having decreased adsorption and increased hydrolysis |
| DE69635503T2 (de) * | 1995-04-11 | 2006-08-17 | Arkray, Inc. | Fructosyl-Aminosäureoxidase und Verfahren zu deren Herstellung |
| DE69603472T2 (de) * | 1995-05-05 | 1999-12-30 | Genzyme Ltd., Haverhill | Bestimmung von glykierten proteinen |
| US5628890A (en) | 1995-09-27 | 1997-05-13 | Medisense, Inc. | Electrochemical sensor |
| US5639672A (en) | 1995-10-16 | 1997-06-17 | Lxn Corporation | Electrochemical determination of fructosamine |
| JP3217687B2 (ja) * | 1996-02-16 | 2001-10-09 | オリエンタル酵母工業株式会社 | 新規ヘキソキナーゼ |
| IL120587A (en) * | 1996-04-04 | 2000-10-31 | Lifescan Inc | Reagent test strip for determination of blood glucose |
| JPH1033177A (ja) * | 1996-07-23 | 1998-02-10 | Kdk Corp | フルクトシルアミノ酸オキシダーゼ |
| US5710248A (en) * | 1996-07-29 | 1998-01-20 | University Of Iowa Research Foundation | Peptide tag for immunodetection and immunopurification |
| US5856104A (en) * | 1996-10-28 | 1999-01-05 | Affymetrix, Inc. | Polymorphisms in the glucose-6 phosphate dehydrogenase locus |
| US5879921A (en) * | 1996-11-07 | 1999-03-09 | Novo Nordisk A/S | Recombinant expression of a glucose oxidase from a cladosporium strain |
| US6069297A (en) * | 1996-12-09 | 2000-05-30 | Sloan-Kettering Institute For Cancer Research | Glucose-6-phosphate dehydrogenase deficient mice and methods of using same |
| US6127345A (en) * | 1997-01-21 | 2000-10-03 | Smithkline Beecham Corporation | Polynucleotides encoding the glucose 6-phosphate dehydrogenase of Streptococcus pneumoniae |
| JP3394262B2 (ja) | 1997-02-06 | 2003-04-07 | セラセンス、インク. | 小体積インビトロ被検体センサー |
| DE69835268T2 (de) * | 1997-04-24 | 2006-11-23 | Arkray, Inc. | Verfahren zum enzymatischen nachweis eines verzuckerungsproteins |
| US5972745A (en) | 1997-05-30 | 1999-10-26 | International Business Machines Corporation | Method or forming self-aligned halo-isolated wells |
| JP3987900B2 (ja) * | 1997-11-26 | 2007-10-10 | アークレイ株式会社 | 糖化タンパク質の測定方法 |
| US5997817A (en) | 1997-12-05 | 1999-12-07 | Roche Diagnostics Corporation | Electrochemical biosensor test strip |
| GB9824282D0 (en) | 1998-11-05 | 1998-12-30 | Microbiological Research Agenc | Delivery of superoxide dismutase to neuronal cells |
| US6352835B1 (en) * | 1998-11-17 | 2002-03-05 | Kyoto Daiichi Kagaku Co. Ltd. | Method of measuring substance in sample using a redox reaction |
| US6380380B1 (en) | 1999-01-04 | 2002-04-30 | Specialty Assays, Inc. | Use of nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucliotide phosphate (NADP) analogs to measure enzyme activities metabolites and substrates |
| JP3949854B2 (ja) | 1999-10-01 | 2007-07-25 | キッコーマン株式会社 | 糖化蛋白質の測定方法 |
| US7276146B2 (en) | 2001-11-16 | 2007-10-02 | Roche Diagnostics Operations, Inc. | Electrodes, methods, apparatuses comprising micro-electrode arrays |
| CN1300763A (zh) | 1999-12-23 | 2001-06-27 | 复旦大学 | 一种新的多肽-已糖激酶蛋白12和编码这种多肽的多核苷酸 |
| CN1313391A (zh) | 2000-03-15 | 2001-09-19 | 上海博德基因开发有限公司 | 一种新的多肽——人已糖激酶蛋白10和编码这种多肽的多核苷酸 |
| CN1323837A (zh) | 2000-05-16 | 2001-11-28 | 上海博德基因开发有限公司 | 一种新的多肽——人已糖激酶蛋白11和编码这种多肽的多核苷酸 |
| EP1404820A2 (en) | 2000-05-19 | 2004-04-07 | Millennium Pharmaceuticals, Inc. | 50365, a hexokinase family member and uses therefor |
| JP4931320B2 (ja) | 2000-06-21 | 2012-05-16 | 協和発酵バイオ株式会社 | 新規なグルコース−6−リン酸デヒドロゲナーゼ |
| CN1333350A (zh) | 2000-07-07 | 2002-01-30 | 上海博德基因开发有限公司 | 一种新的多肽——已糖激酶蛋白9.68和编码这种多肽的多核苷酸 |
| US20040063213A1 (en) * | 2000-09-28 | 2004-04-01 | Kaoru Hirai | Assay method with the use of redox reaction |
| DE10105912A1 (de) | 2001-02-09 | 2002-08-14 | Roche Diagnostics Gmbh | Rekombinante Proteinase K |
| DE10105911A1 (de) | 2001-02-09 | 2002-08-14 | Roche Diagnostics Gmbh | Expression der rekombinanten Proteinase K aus Tritirachium album in Hefe |
| JP3775263B2 (ja) | 2001-08-10 | 2006-05-17 | ニプロ株式会社 | 記録媒体およびこの記録媒体を用いた血糖測定システム |
| DE10155505A1 (de) | 2001-11-13 | 2003-05-22 | Basf Ag | Gene die für Glucose-6-Phosphat-Dehydrogenase Proteine codieren |
| US20030116447A1 (en) | 2001-11-16 | 2003-06-26 | Surridge Nigel A. | Electrodes, methods, apparatuses comprising micro-electrode arrays |
| CN1625601B (zh) * | 2002-01-31 | 2010-10-20 | 爱科来株式会社 | 利用氧化还原反应的糖化蛋白质的测定方法及测定试剂盒 |
| US6863800B2 (en) * | 2002-02-01 | 2005-03-08 | Abbott Laboratories | Electrochemical biosensor strip for analysis of liquid samples |
| US6951728B2 (en) | 2002-05-10 | 2005-10-04 | Lifescan, Inc. | Multilayer reagent test strips to quantify glycated protein in a physiological sample |
| AU2003235973A1 (en) * | 2002-06-07 | 2003-12-22 | Arkray, Inc. | Method of assay by oxidation-reduction reaction with formazan |
| JP2004275168A (ja) | 2003-03-17 | 2004-10-07 | Koji Hayade | フルクトシルアミン酸化酵素 |
| JPWO2007094354A1 (ja) | 2006-02-14 | 2009-07-09 | 独立行政法人産業技術総合研究所 | ヘモグロビンA1cセンサ |
| ES2404059T3 (es) | 2006-07-25 | 2013-05-23 | General Atomics | Procedimientos para analizar el porcentaje de hemoglobina glicada |
| US7943385B2 (en) * | 2006-07-25 | 2011-05-17 | General Atomics | Methods for assaying percentage of glycated hemoglobin |
| TW200912308A (en) | 2007-05-21 | 2009-03-16 | Delta Electronics Inc | Biosensor and composition thereof |
| EP2283149A1 (en) * | 2008-05-13 | 2011-02-16 | General Atomics | Electrochemical biosensor for direct determination of percentage of glycated hemoglobin |
-
2007
- 2007-07-25 ES ES07810786T patent/ES2404059T3/es active Active
- 2007-07-25 WO PCT/US2007/016774 patent/WO2008013874A1/en not_active Ceased
- 2007-07-25 AU AU2007277201A patent/AU2007277201B2/en active Active
- 2007-07-25 EP EP07810786A patent/EP2044444B1/en active Active
- 2007-07-25 CA CA2654981A patent/CA2654981C/en active Active
- 2007-07-25 JP JP2009521827A patent/JP2009544315A/ja not_active Withdrawn
- 2007-07-25 US US11/881,179 patent/US7855079B2/en active Active
- 2007-07-25 CN CN2007800231235A patent/CN101484809B/zh active Active
-
2010
- 2010-11-11 US US12/944,586 patent/US8318501B2/en not_active Expired - Fee Related
-
2012
- 2012-08-27 JP JP2012186627A patent/JP5878096B2/ja not_active Expired - Fee Related
-
2013
- 2013-10-02 JP JP2013207006A patent/JP2013255519A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000210100A (ja) * | 1998-11-17 | 2000-08-02 | Kdk Corp | 酸化還元反応を用いた測定方法 |
| WO2002006519A1 (en) * | 2000-07-14 | 2002-01-24 | Arkray, Inc. | Method of selectively determining glycated hemoglobin |
| WO2002021142A1 (en) * | 2000-09-07 | 2002-03-14 | Wako Pure Chemical Industries, Ltd. | Method of quantifying total hemoglobin and glycohemoglobin |
| WO2005017136A1 (en) * | 2003-07-17 | 2005-02-24 | General Atomics | Methods and compositions for determination of glycated proteins |
Non-Patent Citations (1)
| Title |
|---|
| CLINICAL CHEMISTRY, vol. 49, no. 2, JPN6012027090, 2003, pages 269 - 274, ISSN: 0002235355 * |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2012020744A1 (ja) * | 2010-08-11 | 2013-10-28 | 協和メデックス株式会社 | 糖化ヘモグロビンの測定方法 |
| JPWO2012173185A1 (ja) * | 2011-06-17 | 2015-02-23 | 協和メデックス株式会社 | 糖化ヘモグロビンの測定方法、測定試薬、及び、測定キット |
| WO2012173185A1 (ja) * | 2011-06-17 | 2012-12-20 | 協和メデックス株式会社 | 糖化ヘモグロビンの測定方法、測定試薬、及び、測定キット |
| JPWO2013118743A1 (ja) * | 2012-02-09 | 2015-05-11 | 協和メデックス株式会社 | アスコルビン酸の影響抑制方法 |
| CN104093852A (zh) * | 2012-02-09 | 2014-10-08 | 协和梅迪克斯株式会社 | 抑制抗坏血酸的影响的方法 |
| WO2013118743A1 (ja) * | 2012-02-09 | 2013-08-15 | 協和メデックス株式会社 | アスコルビン酸の影響抑制方法 |
| CN104093852B (zh) * | 2012-02-09 | 2015-11-25 | 协和梅迪克斯株式会社 | 抑制抗坏血酸的影响的方法 |
| JPWO2014192200A1 (ja) * | 2013-05-31 | 2017-02-23 | パナソニックヘルスケアホールディングス株式会社 | 糖化ヘモグロビンを定量する方法 |
| WO2015005257A1 (ja) * | 2013-07-09 | 2015-01-15 | 協和メデックス株式会社 | 糖化ヘモグロビンの測定方法 |
| US10006923B2 (en) | 2013-07-09 | 2018-06-26 | Kyowa Medex Co., Ltd. | Method for measuring glycated hemoglobin |
| WO2018101389A1 (ja) * | 2016-11-30 | 2018-06-07 | 東洋紡株式会社 | ヘモグロビンの糖化率測定方法 |
| JPWO2018101389A1 (ja) * | 2016-11-30 | 2019-10-24 | 東洋紡株式会社 | ヘモグロビンの糖化率測定方法 |
| JP7056577B2 (ja) | 2016-11-30 | 2022-04-19 | 東洋紡株式会社 | ヘモグロビンの糖化率測定方法 |
| WO2021192466A1 (ja) * | 2020-03-26 | 2021-09-30 | 日立化成ダイアグノスティックス・システムズ株式会社 | ヘモグロビンの影響軽減方法、糖化ヘモグロビンの測定方法、糖化ヘモグロビン測定試薬、及び糖化ヘモグロビン測定キット |
| JP7645238B2 (ja) | 2020-03-26 | 2025-03-13 | キヤノンメディカルダイアグノスティックス株式会社 | ヘモグロビンの影響軽減方法、糖化ヘモグロビンの測定方法、糖化ヘモグロビン測定試薬、及び糖化ヘモグロビン測定キット |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2404059T3 (es) | 2013-05-23 |
| US8318501B2 (en) | 2012-11-27 |
| CA2654981A1 (en) | 2008-01-31 |
| AU2007277201B2 (en) | 2014-01-09 |
| US20110189712A1 (en) | 2011-08-04 |
| US20080096230A1 (en) | 2008-04-24 |
| JP5878096B2 (ja) | 2016-03-08 |
| JP2012233922A (ja) | 2012-11-29 |
| CN101484809B (zh) | 2013-12-04 |
| EP2044444B1 (en) | 2013-03-20 |
| CA2654981C (en) | 2016-05-17 |
| JP2013255519A (ja) | 2013-12-26 |
| EP2044444A1 (en) | 2009-04-08 |
| CN101484809A (zh) | 2009-07-15 |
| AU2007277201A1 (en) | 2008-01-31 |
| WO2008013874A1 (en) | 2008-01-31 |
| US7855079B2 (en) | 2010-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5878096B2 (ja) | 糖化ヘモグロビンのパーセントを定量するための方法 | |
| US8338184B2 (en) | Methods for assaying percentage of glycated hemoglobin | |
| JP5870919B2 (ja) | 糖化ヘモグロビンの測定方法 | |
| JP5097758B2 (ja) | 酸化還元反応を用いた糖化タンパク質の測定方法および測定キット | |
| JP4803696B2 (ja) | ヘモグロビンの測定方法及びヘモグロビン糖化率の測定方法 | |
| WO2007072941A1 (ja) | 糖化タンパク質の測定方法 | |
| JPWO2005056823A1 (ja) | 糖化アミンの測定方法 | |
| JP7226955B2 (ja) | 糖化蛋白質の測定 | |
| EP1522593A1 (en) | Method of decomposing protein with sulfonic acid compound | |
| JP4143698B2 (ja) | N−(カルボキシメチルアミノカルボニル)−4,4’−ビス(ジメチルアミノ)ジフェニルアミンナトリウムの誤発色防止方法および前記方法を用いた試薬溶液ならびに測定方法 | |
| EP1452606B1 (en) | Method for measurement using sodium azide | |
| JPWO2018221446A1 (ja) | 糖化ヘモグロビンの測定方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100310 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120528 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120827 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20120827 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130315 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130607 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130614 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20130917 |